{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:14:20Z","timestamp":1779898460561,"version":"3.53.1"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,15]]},"DOI":"10.1093\/infdis\/jix222","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T11:20:40Z","timestamp":1498735240000},"page":"S466-S473","source":"Crossref","is-referenced-by-count":11,"title":["Animal Models for Studying Triazole Resistance in Aspergillus fumigatus"],"prefix":"10.1093","volume":"216","author":[{"given":"Russell E","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"key\n\t\t\t\t20170906122426_CIT0001","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: Can we retain the clinical use of mold-active antifungal azoles?","volume":"62","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0002","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/JCM.02478-15","article-title":"First detection of TR34 L98H and TR46 Y121F T289A Cyp51 mutations in Aspergillus fumigatus isolates in the United States","volume":"54","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170906122426_CIT0003","first-page":"682","article-title":"Azole resistance in Aspergillus fumigatus clinical isolates from an Italian culture collection","volume":"60","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0004","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0005","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007\u20132009","volume":"17","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0006","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3201\/eid2201.151308","article-title":"Azole resistance of Aspergillus fumigatus in immunocompromised patients with invasive aspergillosis","volume":"22","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0007","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0008","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0009","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","year":"2008","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170906122426_CIT0010","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JCM.00502-15","article-title":"High-level pan-azole-resistant Aspergillosis","volume":"53","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170906122426_CIT0011","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.3109\/13693786.2010.499916","article-title":"Aspergillus species intrinsically resistant to antifungal agents","volume":"49","year":"2011","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170906122426_CIT0012","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","article-title":"Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0013","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","year":"2017","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20170906122426_CIT0014","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21-22","year":"2015","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20170906122426_CIT0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/fmb.14.27","article-title":"Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms","volume":"9","year":"2014","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20170906122426_CIT0016","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1128\/AAC.00100-15","article-title":"Environmental isolates of azole-resistant Aspergillus fumigatus in Germany","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0017","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AEM.00231-09","article-title":"Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles","volume":"75","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"key\n\t\t\t\t20170906122426_CIT0018","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/myc.12047","article-title":"Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis","volume":"56","year":"2013","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20170906122426_CIT0019","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.05088-11","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0020","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/S1473-3099(16)30138-4","article-title":"In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management","volume":"16","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0021","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.01599-09","article-title":"Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0022","article-title":"In vivo efficacy of liposomal amphotericin B against wild type and azole-resistant Aspergillus fumigatus isolates in two different immunosuppressed models of invasive aspergillosis","year":"2017","journal-title":"Antimicrob Agent Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drup.2014.06.001","article-title":"The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside","volume":"17","year":"2014","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20170906122426_CIT0024","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/AAC.02226-12","article-title":"Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jac\/dks402","article-title":"Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0026","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/IAI.73.1.114-125.2005","article-title":"The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy","volume":"73","year":"2005","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20170906122426_CIT0027","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/AAC.00787-06","article-title":"Standardization of an experimental murine model of invasive pulmonary aspergillosis","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0028","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1128\/AAC.48.5.1908-1911.2004","article-title":"Novel inhalational murine model of invasive pulmonary aspergillosis","volume":"48","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0029","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.drudis.2014.06.006","article-title":"Animal models of invasive aspergillosis for drug discovery","volume":"19","year":"2014","journal-title":"Drug Discov Today"},{"key":"key\n\t\t\t\t20170906122426_CIT0030","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/IAI.73.1.494-503.2005","article-title":"Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis","volume":"73","year":"2005","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20170906122426_CIT0031","first-page":"1107","article-title":"Dynamic immune cell recruitment after murine pulmonary Aspergillus fumigatus infection under different immunosuppressive regimens","volume":"7","year":"2016","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20170906122426_CIT0032","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1469-0691.2005.01349.x","article-title":"Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis","volume":"12","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170906122426_CIT0033","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/jac\/dkw111","article-title":"Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infection","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0034","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1128\/AAC.00673-10","article-title":"The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) \u03b2-d-glucan and consequences of delayed antifungal therapy","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1124\/dmd.31.6.731","article-title":"The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human","volume":"31","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"key\n\t\t\t\t20170906122426_CIT0036","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/mmy.38.3.209.212","article-title":"Effect of grapefruit juice on serum voriconazole concentrations in the mouse","volume":"38","year":"2000","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170906122426_CIT0037","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jac\/dkf010","article-title":"Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response","volume":"49","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0038","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00259-012-2110-3","article-title":"Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t20170906122426_CIT0039","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/infdis\/169.2.356","article-title":"Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection","volume":"169","year":"1994","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0040","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1128\/AAC.49.4.1642-1645.2005","article-title":"Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0041","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/AAC.45.3.857-869.2001","article-title":"Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia","volume":"45","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0042","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1128\/AAC.02665-15","article-title":"Pharmacokinetics and concentration-dependent efficacy of isavuconazole for treatment of experimental invasive pulmonary aspergillosis","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0043","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1128\/AAC.48.4.1188-1196.2004","article-title":"Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits","volume":"48","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0044","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/AAC.42.11.2898","article-title":"Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits","volume":"42","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/AAC.46.1.12-23.2002","article-title":"Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia","volume":"46","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0046","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/AAC.00329-09","article-title":"Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0047","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1086\/375420","article-title":"Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin","volume":"187","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0048","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/AAC.39.5.1065","article-title":"Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy","volume":"39","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0049","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1164\/ajrccm.152.3.7663787","article-title":"Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression","volume":"152","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170906122426_CIT0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/AAC.38.3.518","article-title":"Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis","volume":"38","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0051","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/506617","article-title":"Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation","volume":"194","year":"2006","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0052","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1086\/377210","article-title":"Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B","volume":"188","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0053","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1093\/jac\/dkw298","article-title":"Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0054","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jac\/40.3.401","article-title":"Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection","volume":"40","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0055","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1016\/j.bmc.2016.11.008","article-title":"Animal models in the pharmacokinetic\/pharmacodynamic evaluation of antimicrobial agents","volume":"24","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"key\n\t\t\t\t20170906122426_CIT0056","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1128\/AAC.00606-10","article-title":"Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0057","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1128\/AAC.00931-09","article-title":"Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0058","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/infdis\/jir023","article-title":"Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapy","volume":"203","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0059","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1128\/AAC.01279-12","article-title":"Posaconazole pharmacodynamic target determination against wild-type and Cyp51 mutant isolates of Aspergillus fumigatus in an in vivo model of invasive pulmonary aspergillosis","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0060","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1128\/AAC.01354-13","article-title":"Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis model","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0061","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1128\/AAC.01083-10","article-title":"Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0062","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/jac\/dkp355","article-title":"An EORTC phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients","volume":"64","author":"Infectious Disease Group of the EORTC","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0063","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2009.334","article-title":"Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study","volume":"45","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t20170906122426_CIT0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12831","article-title":"Mechanisms of echinocandin antifungal drug resistance","volume":"1354","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20170906122426_CIT0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/AAC.01430-12","article-title":"Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0066","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update","volume":"46","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t20170906122426_CIT0067","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/AAC.03850-14","article-title":"Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosis","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0068","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mmcr.2017.03.005","article-title":"Successful treatment of azole-resistant invasive aspergillosis in a bottelnose dolphin with high-dose posaconazole","volume":"16","year":"2017","journal-title":"Medical Mycol Case Rep"},{"key":"key\n\t\t\t\t20170906122426_CIT0069","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1164\/rccm.201510-2104LE","article-title":"Voriconazole-susceptible and voriconazole-resistant Aspergillus fumigatus coinfection","volume":"193","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170906122426_CIT0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jac\/dku410","article-title":"Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0071","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/jac\/dkw323","article-title":"PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay\u00ae in 201 patients with haematological disease suspected for invasive aspergillosis","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0072","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.04907-14","article-title":"Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122426_CIT0073","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.diagmicrobio.2013.04.022","article-title":"Differential expression of ATP-binding cassette and\/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus","volume":"76","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170906122426_CIT0074","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/AAC.00190-08","article-title":"Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins","volume":"52","year":"2008","journal-title":"Antimicrob Agent Chemother"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_3\/S466\/19708772\/jix222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T15:45:50Z","timestamp":1569599150000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jid\/article\/216\/suppl_3\/S466\/4107055\/Animal-Models-for-Studying-Triazole-Resistance-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,15]]},"references-count":74,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2017,9,5]]},"published-print":{"date-parts":[[2017,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix222","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,15]]}}}